Evidence map›Paper›PMID 36815045›Full record

ArticleActa pharmaceutica Sinica. B2023

Sialic acid-mediated photochemotherapy enhances infiltration of CD8

Dezhi Sui, Changzhi Li, Xueying Tang, Xianmin Meng, Junqiang Ding, Qiongfen Yang, Zhaowei Qi, Xinrong Liu, Yihui Deng, Yanzhi Song

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Macrophage senescence in health and diseases.Acta pharmaceutica Sinica. B · 2024
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Dezhi SuiCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Changzhi LiCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xueying TangCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xianmin MengCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Junqiang DingCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Qiongfen YangCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Zhaowei QiCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xinrong LiuCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yihui DengCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yanzhi SongCollege of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Shenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoscenescence plays a key role in the initiation and development of tumors. Furthermore, immunoscenescence also impacts drug delivery and cancer therapeutic efficacy. To reduce the impact of immunosenescence on anti-tumor therapy, this experimental plan aimed to use neutrophils with tumor tropism properties to deliver sialic acid (SA)-modified liposomes into the tumor, kill tumor cells

Indexed as

CD8+ T cellsDoxorubicinImmunosenescenceIndocyanine greenLiposomesNeutrophilsPhotochemotherapySialic acid

Identifiers

PMID36815045
PMCPMC9939359
OpenAlexW4293072406

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.